BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 35143839)

  • 1. The spike protein of SARS-CoV-2 induces endothelial inflammation through integrin α5β1 and NF-κB signaling.
    Robles JP; Zamora M; Adan-Castro E; Siqueiros-Marquez L; Martinez de la Escalera G; Clapp C
    J Biol Chem; 2022 Mar; 298(3):101695. PubMed ID: 35143839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 attachment to host cells is possibly mediated via RGD-integrin interaction in a calcium-dependent manner and suggests pulmonary EDTA chelation therapy as a novel treatment for COVID 19.
    Dakal TC
    Immunobiology; 2021 Jan; 226(1):152021. PubMed ID: 33232865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrin α
    Zhang H; Wang Z; Nguyen HTT; Watson AJ; Lao Q; Li A; Zhu J
    Proc Natl Acad Sci U S A; 2023 Dec; 120(50):e2311913120. PubMed ID: 38060559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A human pluripotent stem cell-based model of SARS-CoV-2 infection reveals an ACE2-independent inflammatory activation of vascular endothelial cells through TLR4.
    Ma Z; Li X; Fan RLY; Yang KY; Ng CSH; Lau RWH; Wong RHL; Ng KK; Wang CC; Ye P; Fu Z; Chin AWH; Lai MYA; Huang Y; Tian XY; Poon LLM; Lui KO
    Stem Cell Reports; 2022 Mar; 17(3):538-555. PubMed ID: 35180397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological and Clinical Consequences of Integrin Binding via a Rogue RGD Motif in the SARS CoV-2 Spike Protein.
    Makowski L; Olson-Sidford W; W-Weisel J
    Viruses; 2021 Jan; 13(2):. PubMed ID: 33498225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 Spike Protein Induces Paracrine Senescence and Leukocyte Adhesion in Endothelial Cells.
    Meyer K; Patra T; Vijayamahantesh ; Ray R
    J Virol; 2021 Aug; 95(17):e0079421. PubMed ID: 34160250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An engineered nano-liposome-human ACE2 decoy neutralizes SARS-CoV-2 Spike protein-induced inflammation in both murine and human macrophages.
    Satta S; Meng Z; Hernandez R; Cavallero S; Zhou T; Hsiai TK; Zhou C
    Theranostics; 2022; 12(6):2639-2657. PubMed ID: 35401811
    [No Abstract]   [Full Text] [Related]  

  • 8. SARS-CoV-2 deregulates the vascular and immune functions of brain pericytes via Spike protein.
    Khaddaj-Mallat R; Aldib N; Bernard M; Paquette AS; Ferreira A; Lecordier S; Saghatelyan A; Flamand L; ElAli A
    Neurobiol Dis; 2021 Dec; 161():105561. PubMed ID: 34780863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 Spike Protein Destabilizes Microvascular Homeostasis.
    Panigrahi S; Goswami T; Ferrari B; Antonelli CJ; Bazdar DA; Gilmore H; Freeman ML; Lederman MM; Sieg SF
    Microbiol Spectr; 2021 Dec; 9(3):e0073521. PubMed ID: 34935423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant ACE2 Expression Is Required for SARS-CoV-2 To Infect Primary Human Endothelial Cells and Induce Inflammatory and Procoagulative Responses.
    Nascimento Conde J; Schutt WR; Gorbunova EE; Mackow ER
    mBio; 2020 Dec; 11(6):. PubMed ID: 33310781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 spike protein induces inflammation via TLR2-dependent activation of the NF-κB pathway.
    Khan S; Shafiei MS; Longoria C; Schoggins JW; Savani RC; Zaki H
    Elife; 2021 Dec; 10():. PubMed ID: 34866574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier.
    Buzhdygan TP; DeOre BJ; Baldwin-Leclair A; Bullock TA; McGary HM; Khan JA; Razmpour R; Hale JF; Galie PA; Potula R; Andrews AM; Ramirez SH
    Neurobiol Dis; 2020 Dec; 146():105131. PubMed ID: 33053430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Cross-Talk between Integrins and Cadherins Leads to a Loss of Vascular Barrier Integrity during SARS-CoV-2 Infection.
    Nader D; Kerrigan SW
    Viruses; 2022 Apr; 14(5):. PubMed ID: 35632633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 Spike Targets USP33-IRF9 Axis
    Mishra R; Banerjea AC
    Front Immunol; 2021; 12():656700. PubMed ID: 33936086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct Activation of Endothelial Cells by SARS-CoV-2 Nucleocapsid Protein Is Blocked by Simvastatin.
    Qian Y; Lei T; Patel PS; Lee CH; Monaghan-Nichols P; Xin HB; Qiu J; Fu M
    J Virol; 2021 Nov; 95(23):e0139621. PubMed ID: 34549987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can the SARS-CoV-2 Spike Protein Bind Integrins Independent of the RGD Sequence?
    Beaudoin CA; Hamaia SW; Huang CL; Blundell TL; Jackson AP
    Front Cell Infect Microbiol; 2021; 11():765300. PubMed ID: 34869067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The SARS-CoV-2 spike protein subunit S1 induces COVID-19-like acute lung injury in Κ18-hACE2 transgenic mice and barrier dysfunction in human endothelial cells.
    Colunga Biancatelli RML; Solopov PA; Sharlow ER; Lazo JS; Marik PE; Catravas JD
    Am J Physiol Lung Cell Mol Physiol; 2021 Aug; 321(2):L477-L484. PubMed ID: 34156871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of Exaggerated Cytokine Production in Human Peripheral Blood Mononuclear Cells by a Recombinant SARS-CoV-2 Spike Glycoprotein S1 and Its Inhibition by Dexamethasone.
    Olajide OA; Iwuanyanwu VU; Lepiarz-Raba I; Al-Hindawi AA
    Inflammation; 2021 Oct; 44(5):1865-1877. PubMed ID: 33860869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 S protein activates NLRP3 inflammasome and deregulates coagulation factors in endothelial and immune cells.
    Villacampa A; Alfaro E; Morales C; Díaz-García E; López-Fernández C; Bartha JL; López-Sánchez F; Lorenzo Ó; Moncada S; Sánchez-Ferrer CF; García-Río F; Cubillos-Zapata C; Peiró C
    Cell Commun Signal; 2024 Jan; 22(1):38. PubMed ID: 38225643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The S1 spike protein of SARS-CoV-2 upregulates the ERK/MAPK signaling pathway in DC-SIGN-expressing THP-1 cells.
    Johnson EL; Ohkawa Y; Kanto N; Fujinawa R; Kuribara T; Miyoshi E; Taniguchi N
    Cell Stress Chaperones; 2024 Apr; 29(2):227-234. PubMed ID: 38453000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.